Canada's Prohibition on Altering the Human Genome
By Françoise Baylis and Alana Cattapan,
Impact Ethics
| 10. 02. 0017
With the development of CRISPR-Cas9 for genome editing, scientists can more safely and more easily insert, delete, or replace DNA. Should this new genome editing tool be used to make changes that will be passed on to future generations?
In Canada, the law currently prohibits altering “the genome of a cell of a human being or in vitro embryo such that the alteration is capable of being transmitted to descendants.” Some people advocate removing this prohibition.
This past summer, Health Canada invited Canadians to comment on its plans to introduce regulations in support of the 2004 Assisted Human Reproduction (AHR) Act. A discussion paper titled Toward a Strengthened Assisted Human Reproduction Act: A Consultation with Canadians on Key Policy Proposals was published. In the discussion paper, Health Canada indicated that amending the prohibition on altering the human genome was beyond the scope of the regulations currently being developed, but that this issue might be addressed at some future time.
In light of this comment by Health Canada suggesting that the legal prohibition on altering the genome of human gametes...
Related Articles
By Judd Boaz and Elise Kinsella, ABC News | 03.17.2026
By Gabriele Pichlhofer and Tino Plümecke, Guest Contributors
| 03.25.2026
A German translation of this interview will be published in May 2026 in the German GID MAGAZIN, which focuses on the market for reproductive technologies. For more information, visit: Gen-ethisches Netzwerk
Egg donation is currently prohibited in Germany and Switzerland, but both countries have been debating its legalization for years. In Switzerland, a legal framework is currently being developed, with a first draft expected by the end of the year. Yet the debate rarely draws on scientific evidence. Instead...
By Charles Pulliam-Moore, The Verge | 03.21.2026
Like many people, director Valerie Veatch was intrigued when OpenAI first released its Sora text-to-video generative AI model to the public in 2024. Though she didn’t fully understand the technology, she was curious about what it could do, and she...
By Ritsuko Kawai, Wired | 03.14.2026
On March 6, Japan’s Ministry of Health, Labor and Welfare officially granted conditional and time-limited marketing authorization to two regenerative medical products derived from reprogrammed iPS cells, marking exactly 20 years since the creation of mouse iPS cells.These will...